These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14602373)

  • 1. Evolution of aminoglycoside resistance phenotypes of four Gram-negative bacteria: an 8-year survey in a University Hospital in Greece.
    Neonakis I; Gikas A; Scoulica E; Manios A; Georgiladakis A; Tselentis Y
    Int J Antimicrob Agents; 2003 Nov; 22(5):526-31. PubMed ID: 14602373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey.
    Over U; Gür D; Unal S; Miller GH;
    Clin Microbiol Infect; 2001 Sep; 7(9):470-8. PubMed ID: 11678929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
    Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K
    Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.
    Gad GF; Mohamed HA; Ashour HM
    PLoS One; 2011 Feb; 6(2):e17224. PubMed ID: 21359143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of aminoglycoside resistance patterns.
    Legakis NJ; Velonaki A; Velonakis EM; Lymberopoulou T
    Chemioterapia; 1986 Jun; 5(3):185-90. PubMed ID: 3087636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
    Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
    Ben Hassen A; Chourou O; Fendri C; Kammoun A; Ben Redjeb S
    Bull Soc Pathol Exot; 1991; 84(2):145-53. PubMed ID: 1914045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups.
    J Chemother; 1995 Jun; 7 Suppl 2():17-30. PubMed ID: 8622108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984.
    Bengtsson S; Bernander S; Brorson JE; Dornbusch K; Forsgren A; Hallander H; Henning C; Holm S; Malmborg AS; Nilsson L
    Scand J Infect Dis; 1986; 18(3):257-63. PubMed ID: 3738436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside resistance patterns in Turkey.
    Akalin HE; Torun M; Alacam R
    Scand J Infect Dis; 1988; 20(2):199-203. PubMed ID: 2840733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility of gram-negative bacilli to aminoglycosides].
    Willke A; Tural D
    Mikrobiyol Bul; 1987 Apr; 21(2):98-102. PubMed ID: 3328818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 56-month prospective surveillance study on the epidemiology of aminoglycoside resistance in a Belgian general hospital.
    Maes P; Vanhoof R
    Scand J Infect Dis; 1992; 24(4):495-501. PubMed ID: 1411316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of enzymatic resistance of E. coli to aminoglycosides.
    Ojdana D; Sieńko A; Sacha P; Majewski P; Wieczorek P; Wieczorek A; Tryniszewska E
    Adv Med Sci; 2018 Mar; 63(1):9-13. PubMed ID: 28763677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of gentamicin resistance in gram-negative bacteria in Czechoslovakia and correlation with its usage.
    Kettner M; Krćméry V
    Drugs Exp Clin Res; 1988; 14(8):511-7. PubMed ID: 2854783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
    Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
    Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.